Multi-Epitope Vaccine Design Using an Immunoinformatic Approach for SARS-CoV-2

Area of Science:

• Immunology
• Vaccinology
• Computational Biology

Background:

• The COVID-19 pandemic caused millions of deaths globally, necessitating vaccines against SARS-CoV-2 variants.
• Rapid viral dissemination and mutation require vaccines targeting multiple epitopes to prevent immune escape.

Purpose of the Study:

• To design and evaluate multi-epitope peptide vaccines against SARS-CoV-2.
• To assess the immunogenicity and efficacy of novel peptide vaccine candidates.

Main Methods:

• In silico identification of B-cell and T-cell epitopes from the SARS-CoV-2 genome.
• Design of multi-epitope peptide vaccines using iNeo-Suite and solid-phase synthesis.
• Immunization of mice with peptide candidates and assessment of humoral and cellular immune responses.

Main Results:

• Identification of 19 high-immunogenic B-cell and 499 HLA-restricted T-cell epitopes.
• Successful elicitation of antigen-specific humoral (IgG) and cellular (IFN-γ secreting T-cells) immune responses in peptide-immunized mice.
• Increased CD19+ cells and higher ratios of IFN-γ-secreting CD4+ and CD8+ T-cells observed in immunized mice.

Conclusions:

• The designed peptide vaccines successfully induced humoral and cellular immunity in a mouse model.
• Further validation through primate studies and human clinical trials is necessary to confirm safety and efficacy.